Vulvovaginal candidiasis (VVC) is one of the most common causes of vaginitis and affects about 75 % of women of reproductive age. In order to better understand the epidemiology and pathogenesis of this disease, we evaluated genetic relatedness among 62 clinical isolates of Candida albicans sequentially obtained from the anus and vagina of patients with sporadic and recurrent VVC. Evaluation of patients' demographic and clinical data, direct examination, and colony forming units (c.f.u.) counts of vaginal and anal samples were also performed. The genotypes of strains were determined with ABC genotyping and Randomly Amplified Polymorphic DNA (RAPD). Genotype A was the most prevalent (93.6 %), followed by genotype C (6.4 %), whereas genotype B was not found. We found the maintenance of the same ABC genotype, regardless of the body site of each patient. Most of the vaginal strains suffered microevolution, whereas most of the anal strains were replaced during the period of study. Vaginal and anal isolates of C. albicans obtained simultaneously from the same patient showed the same ABC genotype and high genetic similarity as determined by RAPD. Genotype A seemed to be dominant in both vaginal and anal isolates of patients with VVC. Our results corroborate the hypothesis that there are 'substrains' of the C. albicans vaginal clone successfully established, which dominate in an apparently random manner over the course of time. It is suggested that the anal reservoir constitutes a possible source for vaginal infection in most of the cases.
INTRODUCTION
Vulvovaginal candidiasis (VVC) is an infection of the vulva and vagina, caused by different species of the genus Candida (Sobel, 1988) . Approximately 75 % of women of reproductive age are affected by VVC (Sobel, 1988) , whereas about 5 % develop recurrent vulvovaginal candidiasis (RVVC), which is defined by the occurrence of three or more episodes of VVC per year (Fidel & Sobel, 1996) . It is widely known that Candida albicans is the main aetiological agent of VVC, accounting for 80-90 % of cases, while 10-20 % of them are caused by non-C. albicans Candida species, such as C. glabrata, C. tropicalis and C. parapsilosis (Dan et al., 2002; Sobel, 1992) . Despite therapeutic advances, VVC has been considered a global public health problem, affecting millions of women of all social strata. It causes great discomfort, impairs sexual relationships and damages work performance (Kent, 1991; Sobel, 1985) .
Several studies have investigated the epidemiology of VVC. Nevertheless, the source of infection remains uncertain, with two main hypotheses for recurrent VVC: reinfection from reservoirs of extra genital sites such as the gastrointestinal tract or through sexual transmission Märdh et al., 2003) , or incomplete eradication of the Candida strain from the vagina (Sobel, 1985) . Therefore, further investigations are mandatory to elucidate the source of infection in women with recurrent VVC. Holanda et al. (2007) observed that patients colonized by C. albicans in the anus are about five times more likely to develop VVC. Of note, it is widely believed that endogenous transmission through the gastrointestinal tract is the main source of vaginal yeasts (Fidel & Sobel, 1996) . ABC genotyping was first described by McCullough et al. (1999) and is based on the presence or absence of a transposable intron of variable size in the gene that encodes the large ribosomal subunit (gene 25S rRNA). This technique is capable of distinguishing four genotypes of C. albicans (genotypes A, B, C and E), besides Candida dubliniensis (genotype D; Tamura et al., 2001) . Odds et al. (2006) stated that ABC genotyping is reliable when strains differ in more than one single nucleotide polymorphism, but it should not be used as a unique method for C. albicans typing. RAPD ('Randomly Amplified Polymophic DNA') genotyping utilizes random 'primers' of approximately 10 bp, which bind to various regions along the genome, generating multiple amplification products and detecting several polymorphic sites. It has been one of the most widely used methods for genotyping pathogenic fungi, including C. albicans (Ao et al., 2014; Brilhante et al., 2012; da Costa et al., 2012; Muzny et al., 2014; Shokri, 2014; Soll, 2000) .
In this study, we evaluated clinical data, and used classical methods for the laboratory based diagnosis of VVC and molecular typing of C. albicans strains sequentially obtained from the vagina and anus of patients with VVC, to better understand the pathogenesis and the source of infection of the disease. To the best of our knowledge, this is the first study evaluating genetic relatedness of C. albicans strains in this specific clinical scenario in Brazil.
METHODS
Study population and strains. We selected 25 strains of C. albicans from the mycological culture collection belonging to the Mycology Laboratory of the Giselda Trigueiro Hospital, obtained from 12 patients between May 2003 and May 2005 (first period of study), while 37 strains of C. albicans were obtained from 10 women who attended Januário Cicco Maternity School and Integrated Clinical Analysis Laboratory, from the Federal University of Rio Grande do Norte, during November 2011 to August 2012 (second period of study, Table 1 ). Only patients who agreed to take part in a surveillance confidential study, in accordance with the Local Research Ethics committee from the University Hospital Onofre Lopes, were enrolled in this study. Of note, the same patient (patient 05) was included in both periods of study (Table 1) . The patients were aged between 20 and 47 years and presented with clinical symptoms of VVC (vaginal discharge, itching, burning, dysuria, oedema, erythema and/or dyspareunia), while no symptoms on the anus or perianal region were observed. Seven patients had sporadic VVC, but did not respond to antifungal therapy, which allowed sequential strains to be obtained (weekly) from the same episode of VVC, while 14 women had the recurrent condition, which allowed sequential strains to be obtained (monthly) from different episodes of VVC. Antifungal treatment started after clinical and laboratorial diagnosis of VVC, at the first time point of sample collections (Table 1) . Patients with clinical evidence of any malignancy and/or AIDS were excluded from the study.
Sampling, culturing procedures and identification of yeasts.
Vaginal and anal secretions obtained from patients in the second period of study were collected with a sterile swab, subsequently placed in saline solution (0.9 % w/v). Samples were subjected to direct examination and inoculated onto the surface of Sabouraud Dextrose Agar (SDA; Difco) supplemented with 50 mg ml 21 of chloramphenicol (Ariston) and 25 mg ml 21 of rose Bengal (Vetec) for c.f.u. counts, and also onto the surface of CHROMagar Candida (Difco) to check for purity and colony colour. Petri dishes were incubated at 30 uC, for 48-96 h. The yeasts isolated were identified according to classical methods (Yarrow, 1998) and phenotypic identification was further confirmed with ABC genotyping (McCullough et al., 1999) . The following reference strains were used: C. albicans ATCC 90028 (genotype A), SC5314 (genotype A), ATCC 90029 (genotype B), CY1123 (genotype C), and C. dubliniensis CBS 7987.
The single primer B14 (59-GATCAAGTCC-39) was used for RAPD analysis. Briefly, 1.0 ml of DNA (40 ng ml 21 ), 2.5 ml of 10 6 PCR buffer (100 mM tris-HCl, pH 8.3, 500 mM KCl, 3.5 mM MgCl 2 ), 5 ml of dNTPmix (100 mM each dNTP), 1.0 ml of primer (50 pmol ml 21 ), 0.13 ml of tween 20 and 1.0 unit of Taq DNA polymerase were added to a final volume of 25 ml. The samples were amplified in a Thermocycler (Amplitherm, TX 96) using the following cycling parameters: one initial cycle of 94 uC for 5 min followed by 45 cycles of 30 s at 94 uC, 1 min at 36 uC, 2 min at 72 uC and a final cycle of 10 min at 72 uC.
PCR products were size-separated by agarose gel electrophoresis (1.2 % agarose) for 2 h at 95 V when ABC genotyping was employed, and for an initial step of 30 min at 100 V followed by a period of 4.5 h at 55 V when RAPD genotyping was used. The gel was stained in a 0.5 mg ml 21 ethidium bromide buffer solution (1 6 tris-acetate-EDTA). C. albicans SC5314 and ATCC 90028 were used as control strains for each PCR.
Computer-assisted RAPD data analysis. Gel images were analysed with the GelCompar II software (Applied Maths). The similarities between the profiles were calculated using the Dice coefficient, to generate the matrices of similarity coefficients to dendrogram constructions. For profile clustering, the unweighted pair-group method with arithmetic averages (UPGMA) with a tolerance of 2 % was used.
Classification of genetic relatedness was based on Soll (2000) . Strains were considered 'Identical' when the DNA fingerprints of isolates were indistinguishable and 'highly related' when the DNA fingerprints were highly similar but nonidentical (about 90 % similarity). Isolates were considered 'moderately related' when they presented a similarity coefficient of about 80 %, according to a similarity coefficient threshold above the average similarity coefficient for a set of presumed unrelated isolates, and 'unrelated' when isolates presented a similarity coefficient near or below this threshold (¡75 %).
Statistical analysis. The Mann-Whitney t-test using the statistical program GraphPad Prism (Graph Pad Software) was used to compare c.f.u. counts between vaginal and anal secretion samples. A P-value of ,0.05 was considered significant.
RESULTS
A total of 62 clinical isolates of C. albicans were included in the present study. Thirty-six isolates were obtained from vaginal secretion while 26 were isolated from the anus of Vaginal secretion samples showed significantly higher c.f.u. counts than the anal secretion samples (P,0.0001, Fig. 1 ). c.f.u. counts from vaginal samples sequentially obtained from the same patient showed no correlation with antifungal treatment and reduction of symptoms presented by most of the patients (Fig. 2) . Nevertheless, on one specific occasion the reduction in c.f.u. counts in sequential vaginal samples obtained from patient 14 was associated with good prognosis, because this patient was cured for VVC, while the increase in c.f.u. counts of the vaginal samples from patient 18 correlated with poor prognosis, since there was a return of all symptoms of VVC in the last culture of this patient (Fig. 2) .
Most of the isolates of C. albicans included in the study belonged to genotype A (58/62; 93.6 %), while only four strains (4/62; 6.4 %), obtained from the same patient (patient 16), belonged to genotype C. Genotypes B, E and D (C. dubliniensis) were not found (Table 1, Fig. 3 ). We were able to find six different clusters with approximately 80 % similarity between the isolates when RAPD genotyping was used (Fig. 4) . We could not detect any cluster enriched for either sporadic or recurrent VVC since most of the clusters were composed of isolates obtained from patients with the two different VVC conditions (Fig. 4 ).
Vaginal and anal strains obtained simultaneously from the same patient showed the same ABC genotype (Table 1) and high genetic similarity (greater than or equal to 90 % similarity) in most of the cases (15/24; 62.5 %) when RAPD was used (Table 3) . Nevertheless, there were some occasions (4/24; 16.7 %) where the anal and vaginal isolates were considered unrelated (less than 75 % similarity; Table 3 ), for instance, strains 01 1CV and 01 1CA, and strains 15 2CV and 15 2CA (Fig. 4) .
Maintenance of the same ABC genotype was observed among vaginal and anal sequential strains (Table 1) . Nevertheless, when RAPD was employed a trend to microevolution (similarity greater than 75 % and less than 100 %) of the sequential vaginal strains isolated from the same patient was detected, being observed in five (5/9; 55.6 %) patients (patients 02, 03 and 12 in the first period of study and patients 14 and 20 in the second period of study). However, a complete vaginal strain replacement (similarity lower than 75 %) was observed in four (4/9; 
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44.4 %) patients (15, 16, 18 and 19) in the second period of study (Table 3 ; Fig. 4) .
A trend to replacement of the anal strain in the course of time was detected when RAPD technique was used, as it can be observed for anal strains obtained from patients 15, 16, 18 and 19 in the second period of study (Fig. 4) , corresponding to four out of six (66.7 %) of the occasions (Table 3) .
DISCUSSION
It is noteworthy that the proliferation of yeast and bud-tohypha transition are important in establishing VVC, as demonstrated by the results of direct examination and c.f.u. counts. In fact, the presence of filamentous structures has been associated with symptoms of VVC (Ferrer, 2000) . Our results relative to c.f.u. counts demonstrate a lack of association between the concentration of C. albicans in the vagina and the clinical manifestations presented by patients with VVC, as observed by other authors (Lopes Consolaro et al., 2004; Giraldo et al., 2000) , although the increase or decrease in c.f.u. counts was related to poor or good prognosis, respectively.
Genotype A seems to be dominant over the other ABC genotypes in both vaginal and anal isolates of patients with VVC. Our results corroborate with the theory that the genotype A of C. albicans is the most prevalent worldwide, which was also observed in several other studies evaluating clinical isolates of C. albicans from various anatomical sites and different geographical regions by ABC genotyping (Emmanuel et al., 2012; Jacobsen et al., 2008; Millar et al., 2002; Odds et al., 2006 Odds et al., , 2007 .
We found by RAPD genotyping several distinct genotypes causing VVC, although most of the isolates were clustered into only two groups (cluster 4 and cluster 5), suggesting the dominance of particular genotypes of C. albicans causing VVC and colonizing the anal mucosa of patients with VVC, corroborating with the results from studies conducted in China Ge et al., 2012; Li & Bai, 2007; Li et al., 2008) . Fig. 4 . Clustering of Candida albicans strains based on the dendrogram generated by GelComparII program using the UPGMA method concerning the banding patterns generated by amplification using the primer B14. The reference strains ATCC 90028 and SC5314 are highlighted. Strains identified by isolate number and clinical condition.
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Other studies also have shown high genetic similarity among isolates of C. albicans obtained simultaneously from the vagina and anus in women with VVC (Sampaio et al., 2003; Shi et al., 2007) . It is suggested that the vaginal pathogenic strains probably originated from the anal reservoir and may be the source of infection of VVC at least for most occasions. Nevertheless, we found genetically unrelated vaginal and anal strains obtained from the same patient for a few cases, suggesting the probable existence of different strains causing vaginal infection and colonizing the anus. Therefore, we cannot completely rule out the possibility of reinfection from sexual transmission or even incomplete eradication of vaginal infecting strains as the cause of recurrence of infection.
Several studies have evaluated the genetic relationship between vaginal isolates of Candida spp. sequentially obtained from patients with RVVC, verifying three different conditions as the most frequent scenario: strain maintenance (Sampaio et al., 2003 (Sampaio et al., , 2005 , microevolution (Chong et al., 2007; Lockhart et al., 1996) or replacement in the course of time (Amouri et al., 2012) .
In our study, the most common scenario was microevolution of the strains of C. albicans in the vaginal environment, cooperating with the hypothesis that there are 'substrains' of the clone established, which dominate in an apparently random manner during the establishment of infection (Lockhart et al., 1996) .
To the best of our knowledge, no studies have evaluated the genetic relationship of anal isolates sequentially obtained of patients with VVC. In our study, we observed that these isolates have a tendency to be replaced, contrary to what was found with regard to vaginal isolates, but consistent with the higher genetic heterogeneity found in colonization sites as compared to sites of infection (Ge et al., 2012; Jacobsen et al., 2008) .
Our results suggest no association between the genotype presented by the strain of C. albicans and the clinical condition of the patient (sporadic or recurrent VVC), confirming the results reported by Lian et al. (2004) .
Finally, we must consider a limitation of our study with regard to the genotyping techniques employed. It is known that RAPD may present low reproducibility and ABC genotyping has limited discriminatory power. Despite the fact that novel genotyping techniques are available for C. albicans with higher discriminatory power and reproducibility, a comparison between RAPD and multilocus sequence typing (MLST) to type C. albicans showed a direct concordance, according to Robles et al. (2004) . In a set of 29 C. albicans isolates evaluated by RAPD, MLST identified three clusters of genetically related isolates, with 82.7 % concordance with RAPD analysis. When MLST was applied to a subset of 22 isolates of unrelated origins, it identified 21 independent diploid sequence types (DSTs), resulting in a discriminatory power of 99.6 %. These DSTs were 96.9 % concordant with the genotypes identified by RAPD analysis (Robles et al., 2004) .
In conclusion, this study contributed to the understanding of the pathogenesis of vaginal candidiasis. Further studies with a higher number of patients and the employment of more discriminatory genotyping techniques are mandatory to confirm these findings. Level of genetic alteration (RAPD genotyping) Vaginal sequencesd N/total (%) Anal sequencesd N/total (%) Replacement 4/9 (44.4 %) 4/6 (66.7 %) Microevolution 5/9 (55.6 %) 2/6 (33.3 %) Maintenance 0/9 (0 %) 0/6 (0 %) *Classification of genetic relatedness according to Soll (2000) . DPair of strains: vaginal and anal clinical strains obtained simultaneously from the same patient at the same time point. These included 24 pairs of strains obtained from 16 patients. dSequences: vaginal and anal strains sequentially obtained (weekly or monthly) from either the vagina or the anus of the same patient. These included nine vaginal sequences obtained from nine patients and six anal sequences obtained from six patients.
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